5× laemmli buffer (Beyotime)
Beyotime is a verified supplier 
Beyotime manufactures this product 
90
Structured Review
Beyotime
5× laemmli buffer
5× Laemmli Buffer, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5%C3%97+laemmli+buffer/5%C3%97+laemmli+buffer/pm40210071-113-8-10
Average 90 stars, based on 1 article reviews
5× Laemmli Buffer, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5%C3%97+laemmli+buffer/5%C3%97+laemmli+buffer/pm40210071-113-8-10
Average 90 stars, based on 1 article reviews
5× laemmli buffer - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Neurokinin-1 Receptor Directly Mediates Glioma Cell Migration by Up-regulation of Matrix Metalloproteinase-2 (MMP-2) and Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) Article Snippet: Protease inhibitor mixture and phosphatase inhibitor mixtures were from Roche Applied Science. Membrane:Article Title: Discovery of Novel 2-Oxoacetamide Derivatives as B3GAT3 Inhibitors for the Treatment of Hepatocellular Carcinoma. Article Snippet: Beta-1,3-glucuronosyltransferase (B3GAT3), overexpressed in hepatocellular carcinoma (HCC) and negatively correlated to prognosis, is a promising target for cancer therapy.. Currently, no studies have reported small molecule inhibitors of B3GAT3.. In this study, we designed and synthesized a series of small-molecule inhibitors of B3GAT3 through virtual screening and structure optimization. Incubation:Article Title: Discovery of Novel 2-Oxoacetamide Derivatives as B3GAT3 Inhibitors for the Treatment of Hepatocellular Carcinoma. Article Snippet: Beta-1,3-glucuronosyltransferase (B3GAT3), overexpressed in hepatocellular carcinoma (HCC) and negatively correlated to prognosis, is a promising target for cancer therapy.. Currently, no studies have reported small molecule inhibitors of B3GAT3.. In this study, we designed and synthesized a series of small-molecule inhibitors of B3GAT3 through virtual screening and structure optimization. SDS Page:Article Title: TFF3 promotes clonogenic survival of colorectal cancer cells through upregulation of EP4 via activation of STAT3. Article Snippet: Protein concentration was measured using a BCA kit (Beyotime). .. Equal amounts of protein were denatured in 5× |